Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Colombia?
GlobalGov holds 428 pharmaceuticals records from 92 distinct buying organisations in Colombia. The most frequent publishers are Instituto Nacional de Vigilancia de Medicamentos y Alimentos // (92 records); Empresa Social Del Estado Región de Salud Soacha. (34 records); Hospital SAN Juan de Dios de Honda ESE (31 records); Hospital Departamental SAN Juan de Dios de Riosucio - Caldas E.S.E (24 records); ESE Hospital Departamental SAN Rafael (15 records); Hospital Departamental Universitario Santa Sofia de Caldas (13 records). Between them the 6 largest account for 49% of everything published, so buying here is spread across many separate authorities.
| Buying organisation | Records | Share |
|---|---|---|
| Instituto Nacional de Vigilancia de Medicamentos y Alimentos // | 92 | 21% |
| Empresa Social Del Estado Región de Salud Soacha. | 34 | 7.9% |
| Hospital SAN Juan de Dios de Honda ESE | 31 | 7.2% |
| Hospital Departamental SAN Juan de Dios de Riosucio - Caldas E.S.E | 24 | 5.6% |
| ESE Hospital Departamental SAN Rafael | 15 | 3.5% |
| Hospital Departamental Universitario Santa Sofia de Caldas | 13 | 3.0% |
What are pharmaceuticals contracts worth in Colombia?
427 of the 428 records publish a contract value. The median is $8,036 and the largest single published value is $1.8M. By size, 406 under $100k, 20 between $100k and $1M, 1 between $1M and $10M. The remaining 1 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 406 | 95% |
| between $100k and $1M | 20 | 4.7% |
| between $1M and $10M | 1 | 0.2% |
| above $10M | 0 | 0.0% |
How long do bidders get to respond to pharmaceuticals tenders in Colombia?
Across the 409 Colombia pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 181 days. A quarter of them allowed 89 days or fewer and a quarter stayed open for more than 333. Short turnarounds are the exception rather than the rule here: only 4 (1.0%) closed within a fortnight of being published.
How often are pharmaceuticals tenders published in Colombia?
Colombia published 9 notices in this category in the last twelve months. Over the last three years there were 424, spread across 16 separate months of activity since 18 February 2021. January is historically the busiest month. No new notice has been published in this category since 25 February 2026, 218 days ago, so treat the figures above as a record of the market rather than as this week's pipeline.
How does Colombia compare with other pharmaceuticals markets?
Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Colombia ranks 15th by number of records. The largest is Germany (4,115 records against 428 here). Within Colombia itself, pharmaceuticals is the 15th largest of the 77 procurement categories tracked here.
Where do the Colombia pharmaceuticals records on this page come from?
These 428 records are collected from 2 official sources: SECOP II (407), SECOP II (21). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Most recent Pharmaceuticals tenders in Colombia
No individual notice in this category currently has a public record page. The market figures above are computed over all 428 records GlobalGov holds for it.
Other procurement categories in Colombia
Pharmaceuticals procurement in other markets
Never Miss a Colombia Government Contract
Finding Colombia tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial